Classification, Labelling and Packaging Regulation

02008R1272-20200101 → 02008R1272-20200501

compared line by line: this provision is too large to compare word by word, so a marked line is a line that changed somewhere

ANNEX VI Harmonised classification and labelling for certain hazardous substances Part 1 of this Annex provides an introduction to the list of harmonised classification and labelling, including information listed for each entry and related classifications and hazard statements in Table 3. … 273 unchanged lines … Table 3.2: The list of harmonised classification and labelling of hazardous substances from Annex I to Directive 67/548/EEC. Table 3 List of harmonised classification and labelling of hazardous substances Converted acute toxicity point estimate according to Table 3.1.2 of Annex I. Index No Chemical name EC No CAS No Classification Labelling Specific Conc. Limits, M-factors Notes ATEs for oral and dermal exposure routes are expressed in mg/kg bw, which stands for milligram per kilogram bodyweight. Index No Chemical name EC No CAS No Classification Labelling Specific Conc. Limits, M-factors and ATEs Notes Hazard Class and Category Code(s) Hazard statement Code(s) Pictogram, Signal Word Code(s) Hazard statement Code(s) Suppl. Hazard statement Code(s) 001-001-00-9 hydrogen 215-605-7 1333-74-0 Flam. Gas 1 … 897 unchanged lines … H315 H410 006-044-00-7 isoproturon (ISO); 3-(4-isopropylphenyl)-1,1-dimethylurea 251-835-4 34123-59-6 Carc. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H373 (blood) H400 H410 GHS08 GHS09 Wng H351 H410 M = 10 006-045-00-2 methomyl (ISO); H373 (blood) H410 M = 10 M = 10 006-045-00-2 methomyl (ISO); 1-(methylthio)ethylideneamino N-methylcarbamate 240-815-0 16752-77-5 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 H300 … 2,483 unchanged lines … Wng H361f*** H302 H317 H410 M=1000 015-101-00-5 phosmet (ISO); O, O-dimethyl phthalimidomethyl S-phosphorodithioate 211-987-4 732-11-6 Acute Tox. 4 * Acute Tox. 4 * S-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl] O,O-dimethyl phosphorodithioate; O,O-dimethyl-S-phthalimidomethyl phosphorodithioate 211-987-4 732-11-6 Repr. 2 Acute Tox. 4 Acute Tox. 3 STOT SE 1 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 Aquatic Chronic 1 H361f H332 H301 H370 (nervous system) H400 H410 GHS07 H410 GHS08 GHS06 GHS09 Wng H312 H302 H410 M = 100 015-102-00-0 tris(2-chloroethyl)phosphate 204-118-5 115-96-8 Carc. 2 Dgr H361f H332 H301 H370 (nervous system) H410 M = 100 M = 100 015-102-00-0 tris(2-chloroethyl)phosphate 204-118-5 115-96-8 Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 H351 … 1,449 unchanged lines … methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate — 79277-27-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 016-097-00-8 1-amino-2-methyl-2-propanethiol hydrochloride 434-480-1 32047-53-3 Acute Tox. 4 * Wng H410 M = 100 M = 100 016-097-00-8 1-amino-2-methyl-2-propanethiol hydrochloride 434-480-1 32047-53-3 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 H302 … 109 unchanged lines … H302 GHS03 GHS07 Dgr H271 H302 017-011-00-1 sodium hypochlorite, solution… % Cl active 231-668-3 7681-52-9 Skin Corr. 1B Aquatic Acute 1 H314 H400 GHS05 H302 017-011-00-1 sodium hypochlorite, solution … % Cl active 231-668-3 7681-52-9 Skin Corr. 1B Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H314 H318 H400 H410 GHS05 GHS09 Dgr H314 H400 EUH031 EUH031: C ≥5 % B H410 EUH031 M = 10 M = 1 EUH031: C ≥ 5 % B 017-012-00-7 calcium hypochlorite 231-908-7 7778-54-3 Ox. Sol. 2 Acute Tox. 4 * Skin Corr. 1B … 601 unchanged lines … H302 GHS07 Wng H332 H302 025-002-00-9 potassium permanganate 231-760-3 7722-64-7 Ox. Sol. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 H272 Repr. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 H272 H361d H302 H400 H410 GHS03 GHS08 GHS07 GHS09 Dgr H272 H361d H302 H410 025-003-00-4 manganese sulphate 232-089-9 7785-87-7 STOT RE 2 * Aquatic Chronic 2 H373 ** … 7,125 unchanged lines … Dgr H330 H311 H301 H372 ** 603-180-00-4 colecalciferol; Vitamin D3 200-673-2 67-97-0 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 H330 H311 H301 H372 ** GHS06 H372 ** 603-180-00-4 colecalciferol; cholecalciferol; vitamin D3 200-673-2 67-97-0 Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 STOT RE 1 H330 H310 H300 H372 GHS06 GHS08 Dgr H330 H311 H301 H372 ** 603-181-00-X tert-butyl methyl ether; MTBE; 2-methoxy-2-methylpropane 216-653-1 1634-04-4 Flam. Liq. 2 H310 H300 H372 inhalation: ATE = 0,05 mg/L (dusts or mists) dermal: ATE = 50 mg/kg bw oral: ATE = 35 mg/kg bw STOT RE 1; H372: C ≥ 3 % STOT RE 2; H373: 0,3 % ≤ C < 3 % 603-181-00-X tert-butyl methyl ether; MTBE; 2-methoxy-2-methylpropane 216-653-1 1634-04-4 Flam. Liq. 2 Skin Irrit. 2 H225 H315 GHS02 GHS07 … 487 unchanged lines … H315 H410 * Eye Irrit. 2; H319:C≥5 % Skin Irrit. 2; H315: C≥5 % 604-014-00-3 chlorocresol; 4-chloro-m-cresol; 4-chloro-3-methylphenol 200-431-6 59-50-7 Acute Tox. 4 * Acute Tox. 4 * H315: C≥5 % 604-014-00-3 chlorocresol; 4-chloro-m-cresol; 4-chloro-3-methylphenol 200-431-6 59-50-7 Acute Tox. 4 Skin Corr. 1C Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 H312 H302 STOT SE 3 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 3 H302 H314 H318 H335 H317 H400 GHS05 GHS07 H400 H412 GHS07 GHS05 GHS09 Dgr H312 H302 H318 Dgr H302 H314 H335 H317 H400 * 604-015-00-9 2,2'-methylenebis-(3,4,6-trichlorophenol); hexachlorophene 200-733-8 70-30-4 Acute Tox. 3 * H410 M = 1 604-015-00-9 2,2'-methylenebis-(3,4,6-trichlorophenol); hexachlorophene 200-733-8 70-30-4 Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 H311 H301 H400 H410 GHS06 GHS09 Dgr H311 H301 H410 * 604-016-00-4 1,2-dihydroxybenzene; pyrocatechol 204-427-5 120-80-9 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 H312 H302 H319 H315 GHS07 Wng H312 H302 H319 H315 604-017-00-X 2,4,5-trichlorophenol 202-467-8 95-95-4 Acute Tox. 4 * H410 * 604-016-00-4 1,2-dihydroxybenzene; pyrocatechol 204-427-5 120-80-9 Carc. 1Β Muta. 2 Acute Tox. 3 Acute Tox. 3 Skin Irrit. 2 Eye Irrit. 2 H350 H341 H311 H301 H315 H319 GHS08 GHS06 Dgr H350 H341 H311 H301 H315 H319 oral: ATE = 300 mg/kg bw dermal: ATE = 600 mg/kg bw 604-017-00-X 2,4,5-trichlorophenol 202-467-8 95-95-4 Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 … 456 unchanged lines … H336 H410 604-090-00-8 4-tert-butylphenol 202-679-0 98-54-4 Repr. 2 Skin Irrit. 2 Eye Dam. 1 H361f Eye Dam. 1 Aquatic Chronic 1 H361f H315 H318 GHS08 H318 H410 GHS08 GHS05 GHS09 Dgr H361f H315 H318 604-091-00-3 etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether 407-980-2 80844-07-1 Lact. H318 H410 M = 1 604-091-00-3 etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether 407-980-2 80844-07-1 Lact. Aquatic Acute 1 Aquatic Chronic 1 H362 H400 … 55 unchanged lines … H318 H373 (kidney) H410 M = 1 M = 100 605-001-00-5 formaldehyde …% 200-001-8 50-00-0 Carc. 1B Muta. 2 M = 100 604-094-00-X isoeugenol; [1] (E)-2-methoxy-4-(prop-1-enyl)phenol; [2] (Z)-2-methoxy-4-(prop-1-enyl)phenol [3] 202-590-7 [1] 227-678-2 [2] 227-633-7 [3] 97-54-1 [1] 5932-68-3 [2] 5912-86-7 [3] Skin Sens. 1A H317 GHS07 Wng H317 Skin Sens. 1A; H317: C ≥ 0,01 % 605-001-00-5 formaldehyde …% 200-001-8 50-00-0 Carc. 1B Muta. 2 Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* Skin Corr. 1B Skin Sens. 1 H350 … 25 unchanged lines … GHS07 Dgr H228 H361d *** H335 T 605-003-00-6 acetaldehyde; ethanal 200-836-8 75-07-0 Flam. Liq. 1 Carc. 2 Eye Irrit. 2 STOT SE 3 H224 H351 H319 H335 GHS02 605-003-00-6 acetaldehyde; ethanal 200-836-8 75-07-0 Flam. Liq. 1 Carc. 1B Muta. 2 STOT SE 3 Eye Irrit. 2 H224 H350 H341 H335 H319 GHS02 GHS08 GHS07 Dgr H224 H351 H319 H335 605-004-00-1 2,4,6-trimethyl-1,3,5-trioxane; paraldehyde 204-639-8 123-63-7 Flam. Liq. 3 H226 GHS02 H350 H341 H335 H319 605-004-00-1 2,4,6-trimethyl-1,3,5-trioxane; paraldehyde 204-639-8 123-63-7 Flam. Liq. 3 H226 GHS02 Wng H226 605-005-00-7 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane; metaldehyde 203-600-2 108-62-3 Flam. Sol. 2 Acute Tox. 4 * H228 H302 GHS02 … 632 unchanged lines … Wng H410 606-046-00-3 reaction mass of cis-and trans-cyclohexadec-8-en-1-one 401-700-2 3100-36-5 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 606-047-00-9 2-benzyl-2-dimethylamino-4-morpholinobutyrophenone 404-360-3 119313-12-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 606-048-00-4 2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one 406-480-1 — Aquatic Chronic 4 H413 — H413 606-049-00-X 4-(trans-4-propylcyclohexyl)acetophenone 406-700-6 78531-61-0 Skin Sens. 1 Wng H410 606-047-00-9 2-benzyl-2-dimethylamino-4′-morpholinobutyrophenone 404-360-3 119313-12-1 Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360D H400 H410 GHS08 GHS09 Dgr H360D H410 606-048-00-4 2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one 406-480-1 — Aquatic Chronic 4 H413 — H413 606-049-00-X 4-(trans-4-propylcyclohexyl)acetophenone 406-700-6 78531-61-0 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 … 1,367 unchanged lines … H319 H335 H315 H317 Skin Sens. 1; H317: C ≥0,1 % 607-096-00-9 maleic anhydride 203-571-6 108-31-6 Acute Tox. 4 * H317 Skin Sens. 1; H317: C ≥0,1 % 607-096-00-9 maleic anhydride 203-571-6 108-31-6 Acute Tox. 4 STOT RE 1 Skin Corr. 1B Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H302 Skin Sens. 1A H302 H372 (respiratory system) (inhalation) H314 H318 H334 H317 GHS07 GHS08 GHS05 Dgr H302 H372 (respiratory system) (inhalation) H314 H334 H317 GHS08 GHS05 GHS07 Dgr H302 H314 H334 H317 607-097-00-4 benzene-1,2,4-tricarboxylic acid 1,2-anhydride; trimellitic anhydride 209-008-0 552-30-7 STOT SE 3 H317 EUH071 Skin Sens. 1A; H317: C ≥ 0,001 % 607-097-00-4 benzene-1,2,4-tricarboxylic acid 1,2-anhydride; trimellitic anhydride 209-008-0 552-30-7 STOT SE 3 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H335 … 55 unchanged lines … Dgr H318 H334 H317 C 607-103-00-5 succinic anhydride 203-570-0 108-30-5 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 H302 H319 H335 GHS07 Wng H302 H319 H335 * Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % 607-104-00-0 cyclopentane-1,2,3,4-tetracarboxylic dianhydride 227-964-7 6053-68-5 Eye Irrit. 2 607-103-00-5 succinic anhydride 203-570-0 108-30-5 Acute Tox. 4 Skin Corr. 1 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H302 H314 H318 H334 H317 GHS07 GHS05 GHS08 Dgr H302 H314 H334 H317 EUH071 607-104-00-0 cyclopentane-1,2,3,4-tetracarboxylic dianhydride 227-964-7 6053-68-5 Eye Irrit. 2 STOT SE 3 H319 H335 GHS07 Wng H319 … 87 unchanged lines … H315 H317 * D 607-113-00-X isobutyl methacrylate 202-613-0 97-86-9 Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 H226 H319 Skin Sens. 1B H226 H335 H315 H317 H400 GHS02 H317 GHS02 GHS07 GHS09 Wng H226 H319 H335 H315 H317 H400 D H317 D 607-114-00-5 ethylene dimethacrylate 202-617-2 97-90-5 STOT SE 3 Skin Sens. 1 H335 H317 GHS07 … 1,584 unchanged lines … H317 607-370-00-8 2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol 412-210-3 41620-33-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 607-371-00-3 3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate 413-410-3 88150-62-3 Aquatic Chronic 4 H413 — H413 607-372-00-9 ethoxylated bisphenol A di-(norbornene carboxylate) 412-410-0 — Aquatic Chronic 3 H412 — H412 607-373-00-4 (±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate 414-200-4 119738-06-6 Muta. 2 Repr. 1B Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 H341 H360Df Wng H410 607-371-00-3 3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate 413-410-3 88150-62-3 Aquatic Chronic 4 H413 — H413 607-372-00-9 ethoxylated bisphenol A di-(norbornene carboxylate) 412-410-0 — Aquatic Chronic 3 H412 — H412 607-373-00-4 quizalofop-P-tefuryl (ISO); (+/–) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate 414-200-4 200509-41-7 Carc. 2 Repr. 2 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H361fd H302 H373 ** H400 H373 H400 H410 GHS08 GHS07 GHS09 Dgr H341 H360Df Wng H351 H361fd H302 H373 ** H410 607-374-00-X 5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride 417-220-1 37441-29-5 Skin Sens. 1 H373 H410 M = 1 M = 1 607-374-00-X 5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride 417-220-1 37441-29-5 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 … 1,721 unchanged lines … H310 H300 H410 M = 10000 M = 10000 608-001-00-3 acetonitrile; cyanomethane 200-835-2 75-05-8 Flam. Liq. 2 M = 10000 607-724-00-1 2,3,5,6-tetrafluoro-4-(methoxymethyl)benzyl (1R,3R)-2,2-dimethyl-3-[(1Z)-prop-1-en-1-yl]cyclopropanecarboxylate; epsilon-metofluthrin — 240494-71-7 Acute Tox. 4 Acute Tox. 3 STOT SE 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H332 H301 H370 (nervous system) H373 H400 H410 GHS06 GHS08 GHS09 Dgr H332 H301 H370 (nervous system) H373 H410 M = 100 M = 100 607-725-00-7 isopropyl (2E,4E,7S)-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate; S-methoprene — 65733-16-6 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 1 M = 1 607-726-00-2 pinoxaden (ISO); 8-(2,6-diethyl-4-methylphenyl)-7-oxo-1,2,4,5-tetrahydro-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropanoate — 243973-20-8 Repr. 2 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 3 H361d H332 H302 H319 H335 H317 H400 H412 GHS08 GHS07 GHS09 Wng H361d H332 H302 H319 H335 H317 H410 inhalation: ATE = 4,63 mg/L (dusts or mists) oral: ATE = 500 mg/kg bw M = 1 607-727-00-8 tetramethrin (ISO); (1,3-dioxo-1,3,4,5,6,7-hexahydro-2H-isoindol-2-yl)methyl 2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate 231-711-6 7696-12-0 Carc. 2 Acute Tox. 4 STOT SE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H302 H371 (nervous system) (inhalation) H400 H410 GHS08 GHS07 GHS09 Wng H351 H302 H371 (nervous system) (inhalation) H410 M = 100 M = 100 607-728-00-3 (1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate 214-619-0 1166-46-7 Carc. 2 Acute Tox. 4 STOT SE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H302 H371 (nervous system) (inhalation) H400 H410 GHS08 GHS07 GHS09 Wng H351 H302 H371 (nervous system) (inhalation) H410 M = 100 M = 100 607-729-00-9 mesosulfuron-methyl (ISO); methyl 2-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-α-(methanesulfonamido)-p-toluate; — 208465-21-8 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 100 M = 100 607-730-00-4 spirodiclofen (ISO); 3-(2,4-dichlorophenyl)-2-oxo-1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrate — 148477-71-8 Carc. 1B Repr. 2 STOT RE 2 Skin Sens. 1B Aquatic Chronic 1 H350 H361f H373 H317 H410 GHS08 GHS07 GHS09 Dgr H350 H361f H373 H317 H410 M = 10 607-731-00-X sodium methyl [(4-aminophenyl)sulphonyl]carbamate; sodium methyl (EZ)-sulfanilylcarbonimidate; asulam-sodium 218-953-8 2302-17-2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 M = 1 M = 1 607-732-00-5 salicylic acid 200-712-3 69-72-7 Repr. 2 Acute Tox. 4 Eye Dam. 1 H361d H302 H318 GHS08 GHS07 GHS05 Dgr H361d H302 H318 608-001-00-3 acetonitrile; cyanomethane 200-835-2 75-05-8 Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 H225 H332 … 508 unchanged lines … H319 H410 M = 10 A 608-067-00-3 3,7-dimethylocta-2,6-dienenitrile 225-918-0 5146-66-7 Muta. 1B H340 GHS08 Dgr H340 609-001-00-6 1-nitropropane 203-544-9 108-03-2 Flam. Liq. 3 Dgr H340 608-068-00-9 flutianil (ISO); (2Z)-{[2-fluoro-5-(trifluoromethyl)phenyl]thio}[3-(2-methoxyphenyl)-1,3-thiazolidin-2-ylidene]acetonitrile — 958647-10-4 Aquatic Chronic 1 H410 GHS09 Wng H410 M = 100 609-001-00-6 1-nitropropane 203-544-9 108-03-2 Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * H226 … 5,532 unchanged lines … H411 EUH071 8 9 612-292-00-2 methylhydrazine 200-471-4 60-34-4 Carc. 1B H350 GHS08 Dgr H350 613-001-00-1 ethyleneimine; aziridine 205-793-9 151-56-4 Flam. Liq. 2 Dgr H350 612-293-00-8 reaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy)but-2-ylamine 447-920-2 - Repr. 2 Acute Tox. 4 Skin Corr. 1B Eye Dam. 1 H361f H302 H314 H318 GHS08 GHS07 GHS05 Dgr H361f H302 H314 EUH071 613-001-00-1 ethyleneimine; aziridine 205-793-9 151-56-4 Flam. Liq. 2 Carc. 1B Muta. 1B Acute Tox. 2 * … 1,400 unchanged lines … GHS09 Dgr H360D H410 M = 1000 M = 1000 613-167-00-5 reaction mass of: 5-chloro-2- methyl-4-isothiazolin-3-one [EC no. 247-500-7]and 2-methyl-2H -isothiazol-3- one [EC no. 220-239-6] (3:1); reaction mass of: 5-chloro-2- methyl-4-isothiazolin-3-one [EC no. 247-500-7]and 2-methyl-4-isothiazolin-3- one [EC no. 220-239-6] (3:1) — 55965-84-9 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 M = 1000 613-167-00-5 reaction mass of 5-chloro-2-methyl-2H-isothiazol-3-one and 2-methyl-2H-isothiazol-3-one (3:1) — 55965-84-9 Acute Tox. 2 Acute Tox. 2 Acute Tox. 3 Skin Corr. 1C Eye Dam. 1 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H301 H314 H318 H317 H400 H410 GHS06 GHS05 GHS09 Dgr H331 H311 Dgr H330 H310 H301 H314 H317 H410 Skin Corr. 1B; H314: C ≥0,6 % Skin Irrit. 2; H315: 0,06 % ≤ C < 0,6 % Eye Irrit. 2; H319: 0,06 % ≤ C < 0,6 % Skin Sens. 1; H317: C ≥ 0,0015 % 613-168-00-0 1-vinyl-2-pyrrolidone 201-800-4 88-12-0 Carc. 2 H410 EUH071 Skin Corr. 1C; H314: C ≥ 0,6 % Skin Irrit. 2; H315: 0,06 % ≤ C < 0,6 % Eye Dam. 1; H318: C ≥ 0,6 % Eye Irrit. 2; H319: 0,06 % ≤ C < 0,6 % Skin Sens. 1A; H317: C ≥ 0,0015 % M = 100 M = 100 B 613-168-00-0 1-vinyl-2-pyrrolidone 201-800-4 88-12-0 Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * … 316 unchanged lines … H410 GHS08 GHS09 Wng H361d*** H373** H410 M = 1000 613-205-00-0 propiconazole(ISO); (±) 1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H—1,2,4-triazole 262-104-4 60207-90-1 Acute Tox. 4 * H410 M = 1000 613-205-00-0 propiconazole (ISO); (2RS,4RS;2RS,4SR)-1-{[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl}-1H-1,2,4-triazole 262-104-4 60207-90-1 Repr. 1B Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 Aquatic Chronic 1 H360D H302 H317 H400 H410 GHS07 H410 GHS08 GHS07 GHS09 Wng H302 Dgr H360D H302 H317 H410 613-206-00-6 fenamidone (ISO); H410 M = 1 M = 1 613-206-00-6 fenamidone (ISO); (S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one — 161326-34-7 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 … 807 unchanged lines … H301 H336 H410 M = 100 M = 100 614-001-00-4 nicotine (ISO); M = 100 613-326-00-9 2-methylisothiazol-3(2H)-one 220-239-6 2682-20-4 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B Eye Dam. 1 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 H330 H311 H301 H314 H318 H317 H400 H410 GHS05 GHS06 GHS09 Dgr H330 H311 H301 H314 H317 H410 EUH071 Skin Sens. 1A; H317: C ≥ 0,0015 % M = 10 M = 1 613-327-00-4 pyroxsulam (ISO); N-(5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2-methoxy-4-(trifluoromethyl)pyridine-3-sulfonamide — 422556-08-9 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 M = 100 M = 100 613-328-00-X 1-vinylimidazole 214-012-0 1072-63-5 Repr. 1B H360D GHS08 Dgr H360D Repr. 1B; H360D: C ≥ 0,03 % 614-001-00-4 nicotine (ISO); 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine 200-193-3 54-11-5 Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 Aquatic Chronic 2 H330 H310 H300 H411 GHS06 GHS09 Dgr H330 H310 H300 H411 inhalation: ATE = 0.19 mg/L (dusts or mists) ATE = 0,19 mg/L (dusts or mists) dermal: ATE = 70 mg/kg ATE = 70 mg/kg bw oral: ATE = 5 mg/kg 614-002-00-X salts of nicotine — — Acute Tox. 2 * ATE = 5 mg/kg bw 614-002-00-X salts of nicotine — — Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 2 H330 … 1,827 unchanged lines … Dgr H351 H360D H302 H411 617-001-00-2 di-tert-butyl peroxide 203-733-6 110-05-4 Org. Perox. E Flam. Liq. 2 Muta. 2 H242 H411 616-224-00-2 amisulbrom (ISO); 3-(3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamide — 348635-87-0 Carc. 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H319 H400 H410 GHS08 GHS07 GHS09 Wng H351 H319 H410 M = 10 M = 10 617-001-00-2 di-tert-butyl peroxide 203-733-6 110-05-4 Org. Perox. E Flam. Liq. 2 Muta. 2 H242 H225 H341 GHS02 GHS08 … 24,954 unchanged lines … S: 61 650-055-00-5 silver sodium zirconium hydrogenphosphate 422-570-3 155925-27-2 N; R50-53 N R: 50/53 S: 60-61